Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.355 SEK | +0.37% | 0.00% | -66.08% |
05-15 | Transcript : Scandion Oncology A/S - Special Call | |
03-21 | Scandion Oncology Reports Updated Phase II Corist Data, Including Topline Overall Survival | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-66.08% | 5.14M | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- SCOL Stock
- News Scandion Oncology A/S
- Scandion Oncology Obtains Patent for Combination Cancer Treatment Drug